Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.)
oleh: Jonathan Weiss, Martin Peifer, Carmen D. Herling, Lukas P. Frenzel, Michael Hallek
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2019-11-01 |
Deskripsi
No description available for this item.